Skip to main content

Table 1 Patient demographics

From: Spermine oxidase (SMO) activity in breast tumor tissues and biochemical analysis of the anticancer spermine analogues BENSpm and CPENSpm

Patient No.

Age year

TNM

Tumoral markers

Tumor grade

Histological type of cancer

1

67

T4 N1A M0

E90%, P90%, K10%, C1+

II

IDC

2

86

T1C N1 M0

E90%, P90%, K15%, C2+

II

IDC

3

80

T1B N0 M0

E90%, P90%, K15%, CNEG

II

IDC

4

71

T1C N0 M0

ENEG, PNEG, K40%, C3+

III

IDC

5

75

T2 N1 M0

ENEG, PNEG, K30%, CNEG

III

IDC

6

62

T1C N0 M0

E90%, P90%, K30%, C2+

II

IDC

7

84

T4 N1 M0

E90%, PNEG, K40%, C3+

III

IDC

8

76

T2 N0 M0

E90%, P90%, K30%, CNEG

III

IDC

9

88

T2 N0 M0

E90%, P90%, K15%, C1+

II

IDC

10

50

T2 N2A M0

E90%, P90%, K20%, C2+

III

IDC

11

85

T1C N1 M0

ENEG, PNEG, K40%, CNEG

III

IDC

12

82

T4 N1 M0

E90%, P40%, K20%, C3+

II

IDC

13

53

T2 N2 M0

E90%, P90%, K30%, CNEG

III

ILC

14

68

T2 N1 M0

E90%, P90%, K20%, C1+

II

IDC

15

66

T2 N0 M0

E90%, P90%, K30%, C2+

III

IDC

16

73

T2 N1 M0

E80%, P70%, K20%, C3+

II

IDC

17

64

T2 N0 M0

E80%, P70%, K30%, C2+

III

IDC

18

63

TIS

ENEG, PNEG, K40%, C3+

III

ISDC

19

47

T2 N0 M0

E90%, P90%, K30%, CNEG

III

IDC

20

70

T1C N0M0

ENEG, PNEG, K40%, C3+

III

IDC

  1. C: c-erb; E: estrogen receptor; K: Ki67; NEG: negative; P: progesteron receptor; TNM: tumor, node, metastasis; IDC: Invasive Ductal Carcinoma; ILC: Invasive Lobular Carcinoma; DCIS: In situ Ductal Carcinoma; TIS: In SituTumor.